On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

Genomics (TXG) has drawn investor attention after recent share price gains over the past week, month, and past 3 months, prompting closer scrutiny of its current valuation and business fundamentals.

Fintel reports that on March 31, 2026, William Blair upgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Market Perform to Outperform. Analyst Price Forecast Suggests 4.45% Upside As of March ...

William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

Cathie Wood’s ARK Invest actively rotated out of large-cap technology, crypto-linked equities, and consumer internet names ...

Anthropic has acquired Coefficient Bio, a stealth biotech startup with fewer than 10 people, for $400 million in stock. The ...

Merck is partnering with Infinimmune in a deal worth up to $838 million to leverage AI-driven antibody discovery. Do you know ...

Loop initiates Visa and Mastercard as buy Loop says both credit card stocks are well positioned. "Through the many avenues to ...

ARK Invest sold over $87M in Nvidia and Meta shares last week while purchasing Circle Internet and CoreWeave in a strategic ...

Eric Green, MD, PhD, Chief Medical Officer of Illumina, was awarded the Distinguished Service Award by board members of The Genome Partnership—the nonprofit organization that has organized the ...

Defense Secretary Pete Hegseth said the coming days of the war with Iran will be decisive, adding that the U.S. would "negotiate with bombs" until Tehran relinquishes its ambitions. "Iran knows that, ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...